Europe Biomarker Test Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Biomarker Test Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Cancer Market Performance (Volume)
  • 2.1.2 Cardiovascular Market Performance (Volume)
  • 2.1.3 Infectious Diseases Market Performance (Volume)
  • 2.1.4 Central Nervous System Market Performance (Volume)
  • 2.1.5 Others Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Cancer Market Performance (Value)
  • 2.1.2 Cardiovascular Market Performance (Value)
  • 2.1.3 Infectious Diseases Market Performance (Value)
  • 2.1.4 Central Nervous System Market Performance (Value)
  • 2.1.5 Others Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Pharma & Biotech Companies Market Performance (Volume)
  • 3.1.2 Diagnostic Tool Companies Market Performance (Volume)
  • 3.1.3 Healthcare IT/Big Data Companies Market Performance (Volume)
  • 3.1.4 Clinical laboratories Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 F. Hoffmann-La Roche AG
  • 4.1.1 F. Hoffmann-La Roche AG Profiles
  • 4.1.2 F. Hoffmann-La Roche AG Product Information
  • 4.1.3 F. Hoffmann-La Roche AG Biomarker Test Business Performance
  • 4.1.4 F. Hoffmann-La Roche AG Biomarker Test Business Development and Market Status
• 4.2 Novartis AG
  • 4.2.1 Novartis AG Profiles
  • 4.2.2 Novartis AG Product Information
  • 4.2.3 Novartis AG Biomarker Test Business Performance
  • 4.2.4 Novartis AG Biomarker Test Business Development and Market Status
• 4.3 PFIZER INC
  • 4.3.1 PFIZER INC Profiles
  • 4.3.2 PFIZER INC Product Information
  • 4.3.3 PFIZER INC Biomarker Test Business Performance
  • 4.3.4 PFIZER INC Biomarker Test Business Development and Market Status
• 4.4 GlaxoSmithKline
  • 4.4.1 GlaxoSmithKline Profiles
  • 4.4.2 GlaxoSmithKline Product Information
  • 4.4.3 GlaxoSmithKline Biomarker Test Business Performance
  • 4.4.4 GlaxoSmithKline Biomarker Test Business Development and Market Status
• 4.5 GE Healthcare
  • 4.5.1 GE Healthcare Profiles
  • 4.5.2 GE Healthcare Product Information
  • 4.5.3 GE Healthcare Biomarker Test Business Performance
  • 4.5.4 GE Healthcare Biomarker Test Business Development and Market Status
• 4.6 Medtronics
  • 4.6.1 Medtronics Profiles
  • 4.6.2 Medtronics Product Information
  • 4.6.3 Medtronics Biomarker Test Business Performance
  • 4.6.4 Medtronics Biomarker Test Business Development and Market Status
• 4.7 Quest Diagnostics
  • 4.7.1 Quest Diagnostics Profiles
  • 4.7.2 Quest Diagnostics Product Information
  • 4.7.3 Quest Diagnostics Biomarker Test Business Performance
  • 4.7.4 Quest Diagnostics Biomarker Test Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Europe Biomarker Test Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Biomarker Test Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Biomarker Test Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Biomarker Test Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Biomarker Test Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Biomarker Test Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Biomarker Test Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Biomarker Test Market Performance (Sales Point)

• 7.1 Europe Biomarker Test Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Biomarker Test Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Biomarker Test Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Biomarker Test Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Biomarker Test Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Pharma & Biotech Companies Industry
• 11.2 Diagnostic Tool Companies Industry
• 11.3 Healthcare IT/Big Data Companies Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Biomarker Test Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Biomarker Test Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Biomarker Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Cancer Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Cardiovascular Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Infectious Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 Central Nervous System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Pharma & Biotech Companies Sales and and Growth Rate 2019-2024
  • 12.4.3 Diagnostic Tool Companies Sales and and Growth Rate 2019-2024
  • 12.4.4 Healthcare IT/Big Data Companies Sales and and Growth Rate 2019-2024
  • 12.4.5 Clinical laboratories Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Biomarker Test Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Biomarker Test Gross Profit Trend 2019-2024

13 Conclusion